Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-α production by ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2002-05-24

AUTHORS

Y Matsuki, L Li, H-C Hsu, P A Yang, R Zheng, C K Edwards, I H Chaudry, H-G Zhang, J D Mountz

ABSTRACT

The elevation of soluble Fas (sFas) in the sera of patients with liver disease suggests a role for sFas in the disease process; whether it is protective or not is controversial. To determine the effects of sFas on Fas-induced liver apoptosis, we manipulated mice to produce sFas by transfecting them in vivo with different amounts of an adenovirus that produces mouse sFas driven by the CMV promoter (AdsFas). Fas-mediated apoptosis was induced by administration of anti-mouse Fas (Jo2; 10 μg/mouse) one week later. The administration of AdsFas (103, 107, or 109 pfu/mouse), which was associated with only minimal side-effects, resulted in a significant reduction in the liver transaminase levels and mortality of the mice on challenge with Jo2, as compared to control mice treated with AdLacZ. However, the protective effect of AdsFas was not complete. The possibility that Jo2-induction of TNF-α in the Kupffer cells of the liver contributes to the pathology was therefore tested. Although administration of soluble TNF receptor (sTNFRI) alone did not protect the mice from the lethal effects of Jo2, administration of sTNFRI (200 μg/mouse) after infection with AdsFas (109 pfu/mouse) resulted in 100% survival of the mice on challenge with Jo2. To confirm that the production of TNF-α by Kupffer cells produce the lethal effects of Jo2 that remained after treatment with AdsFas, these cells were selectively ablated by treatment of the mice with gadolinium chloride prior to challenge with Jo2. This treatment greatly reduced early mortality and hepatocellular damage as well as TNF-α production 6 h after injection of Jo2. These results indicate that: (1) AdsFas prevents Jo2-induced apoptosis of hepatocytes; (2) In addition to mediating Fas-mediated apoptosis of hepatocytes, Jo2 can separately induce TNF-α production by Kupffer cells resulting in early mortality, and (3) Optimal protection from Jo2-induced mortality can be achieved by protection of liver cells by pretreatment with both AdsFas and sTNFRI. More... »

PAGES

626-635

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.cdd.4401016

DOI

http://dx.doi.org/10.1038/sj.cdd.4401016

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030089876

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12032671


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gadolinium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kupffer Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fas Receptor", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuki", 
        "givenName": "Y", 
        "id": "sg:person.01010406464.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010406464.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "L", 
        "id": "sg:person.01062167667.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062167667.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hsu", 
        "givenName": "H-C", 
        "id": "sg:person.01263522210.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263522210.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "P A", 
        "id": "sg:person.016612437322.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612437322.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Surgical Research and Department of Surgery, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Center for Surgical Research and Department of Surgery, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zheng", 
        "givenName": "R", 
        "id": "sg:person.0740752222.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740752222.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen Inc. Thousand Oaks, CA 91320, California, USA", 
          "id": "http://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc. Thousand Oaks, CA 91320, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Edwards", 
        "givenName": "C K", 
        "id": "sg:person.010200342162.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010200342162.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Surgical Research and Department of Surgery, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Center for Surgical Research and Department of Surgery, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chaudry", 
        "givenName": "I H", 
        "id": "sg:person.0644012610.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644012610.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Birmingham Veterans Administration Medical Center, AL 35233, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.280808.a", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
            "Birmingham Veterans Administration Medical Center, AL 35233, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "H-G", 
        "id": "sg:person.01054374560.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054374560.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Birmingham Veterans Administration Medical Center, AL 35233, Birmingham, Alabama, USA", 
          "id": "http://www.grid.ac/institutes/grid.280808.a", 
          "name": [
            "Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA", 
            "Birmingham Veterans Administration Medical Center, AL 35233, Birmingham, Alabama, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mountz", 
        "givenName": "J D", 
        "id": "sg:person.07550405624.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/3488", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051953130", 
          "https://doi.org/10.1038/3488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0497-409", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028570463", 
          "https://doi.org/10.1038/nm0497-409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/364806a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050650199", 
          "https://doi.org/10.1038/364806a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-05-24", 
    "datePublishedReg": "2002-05-24", 
    "description": "The elevation of soluble Fas (sFas) in the sera of patients with liver disease suggests a role for sFas in the disease process; whether it is protective or not is controversial. To determine the effects of sFas on Fas-induced liver apoptosis, we manipulated mice to produce sFas by transfecting them in vivo with different amounts of an adenovirus that produces mouse sFas driven by the CMV promoter (AdsFas). Fas-mediated apoptosis was induced by administration of anti-mouse Fas (Jo2; 10\u2009\u03bcg/mouse) one week later. The administration of AdsFas (103, 107, or 109\u2009pfu/mouse), which was associated with only minimal side-effects, resulted in a significant reduction in the liver transaminase levels and mortality of the mice on challenge with Jo2, as compared to control mice treated with AdLacZ. However, the protective effect of AdsFas was not complete. The possibility that Jo2-induction of TNF-\u03b1 in the Kupffer cells of the liver contributes to the pathology was therefore tested. Although administration of soluble TNF receptor (sTNFRI) alone did not protect the mice from the lethal effects of Jo2, administration of sTNFRI (200\u2009\u03bcg/mouse) after infection with AdsFas (109\u2009pfu/mouse) resulted in 100% survival of the mice on challenge with Jo2. To confirm that the production of TNF-\u03b1 by Kupffer cells produce the lethal effects of Jo2 that remained after treatment with AdsFas, these cells were selectively ablated by treatment of the mice with gadolinium chloride prior to challenge with Jo2. This treatment greatly reduced early mortality and hepatocellular damage as well as TNF-\u03b1 production 6\u2009h after injection of Jo2. These results indicate that: (1) AdsFas prevents Jo2-induced apoptosis of hepatocytes; (2) In addition to mediating Fas-mediated apoptosis of hepatocytes, Jo2 can separately induce TNF-\u03b1 production by Kupffer cells resulting in early mortality, and (3) Optimal protection from Jo2-induced mortality can be achieved by protection of liver cells by pretreatment with both AdsFas and sTNFRI.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.cdd.4401016", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2425848", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2454874", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2454082", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2446046", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1112551", 
        "issn": [
          "1350-9047", 
          "1476-5403"
        ], 
        "name": "Cell Death & Differentiation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "Kupffer cells", 
      "apoptosis of hepatocytes", 
      "early mortality", 
      "liver transaminase levels", 
      "soluble TNF receptors", 
      "sera of patients", 
      "production of TNF", 
      "Fas-induced liver apoptosis", 
      "lethal effects", 
      "effects of SFA", 
      "transaminase levels", 
      "liver disease", 
      "hepatocellular damage", 
      "soluble Fas", 
      "protective effect", 
      "disease process", 
      "TNF", 
      "Jo2-induced apoptosis", 
      "liver apoptosis", 
      "TNF receptor", 
      "gadolinium chloride", 
      "Fas-mediated apoptosis", 
      "mice", 
      "mortality", 
      "liver cells", 
      "administration", 
      "one week", 
      "optimal protection", 
      "sTNFRI", 
      "significant reduction", 
      "SFA", 
      "apoptosis", 
      "treatment", 
      "hepatocytes", 
      "CMV promoter", 
      "Jo2", 
      "cells", 
      "AdLacZ.", 
      "FA", 
      "patients", 
      "infection", 
      "disease", 
      "liver", 
      "pathology", 
      "protects", 
      "serum", 
      "weeks", 
      "receptors", 
      "survival", 
      "effect", 
      "adenovirus", 
      "injection", 
      "vivo", 
      "elevation", 
      "pretreatment", 
      "protection", 
      "damage", 
      "levels", 
      "production", 
      "role", 
      "reduction", 
      "promoter", 
      "challenges", 
      "addition", 
      "results", 
      "possibility", 
      "amount", 
      "chloride", 
      "different amounts", 
      "process"
    ], 
    "name": "Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-\u03b1 production by Kupffer cells", 
    "pagination": "626-635", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030089876"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.cdd.4401016"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12032671"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.cdd.4401016", 
      "https://app.dimensions.ai/details/publication/pub.1030089876"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_359.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.cdd.4401016"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401016'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401016'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401016'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401016'


 

This table displays all metadata directly associated to this object as RDF triples.

289 TRIPLES      22 PREDICATES      117 URIs      106 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.cdd.4401016 schema:about N05d3d8e6b2464c9a869d1f1e61c670a5
2 N30b43525ebda4583988a631949cae70c
3 N4238563f00b942429f76e553b30665ea
4 N5bc7348565ef4b0cbf67126d314efb88
5 N6a6b1454f26c475995d4d22a4469593c
6 N6fa3a95bcf5b4853a9d7b3a195c88bed
7 N7af22a04eb6c404a92d37c75090b059d
8 N8172de6f65484696bc66f627bcb3c456
9 N916de416f617425584ea268283ffa7d9
10 Nc1e7c3c96b4f417db7c68416937ee681
11 Nc46bb39e6bea468f850d159924b511b1
12 Nc68ef871d1834a769864ce0aeea6b451
13 Nc6b13588f52649308f096bc10a42862d
14 Ncf1ad0912ba44a4682eec3c8861a94a4
15 Nd5beeda543534ad7a77b9c225c5954f2
16 Ne2ad258e347d4fbeb2f09ba7e5c3576b
17 Ne90a89aa79fe4dc084444e2ad4495695
18 Neac54be6e2084cd1ad7e3f0108f39c5a
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N9f28e61484c5436f8238109635630174
22 schema:citation sg:pub.10.1038/3488
23 sg:pub.10.1038/364806a0
24 sg:pub.10.1038/nm0497-409
25 schema:datePublished 2002-05-24
26 schema:datePublishedReg 2002-05-24
27 schema:description The elevation of soluble Fas (sFas) in the sera of patients with liver disease suggests a role for sFas in the disease process; whether it is protective or not is controversial. To determine the effects of sFas on Fas-induced liver apoptosis, we manipulated mice to produce sFas by transfecting them in vivo with different amounts of an adenovirus that produces mouse sFas driven by the CMV promoter (AdsFas). Fas-mediated apoptosis was induced by administration of anti-mouse Fas (Jo2; 10 μg/mouse) one week later. The administration of AdsFas (103, 107, or 109 pfu/mouse), which was associated with only minimal side-effects, resulted in a significant reduction in the liver transaminase levels and mortality of the mice on challenge with Jo2, as compared to control mice treated with AdLacZ. However, the protective effect of AdsFas was not complete. The possibility that Jo2-induction of TNF-α in the Kupffer cells of the liver contributes to the pathology was therefore tested. Although administration of soluble TNF receptor (sTNFRI) alone did not protect the mice from the lethal effects of Jo2, administration of sTNFRI (200 μg/mouse) after infection with AdsFas (109 pfu/mouse) resulted in 100% survival of the mice on challenge with Jo2. To confirm that the production of TNF-α by Kupffer cells produce the lethal effects of Jo2 that remained after treatment with AdsFas, these cells were selectively ablated by treatment of the mice with gadolinium chloride prior to challenge with Jo2. This treatment greatly reduced early mortality and hepatocellular damage as well as TNF-α production 6 h after injection of Jo2. These results indicate that: (1) AdsFas prevents Jo2-induced apoptosis of hepatocytes; (2) In addition to mediating Fas-mediated apoptosis of hepatocytes, Jo2 can separately induce TNF-α production by Kupffer cells resulting in early mortality, and (3) Optimal protection from Jo2-induced mortality can be achieved by protection of liver cells by pretreatment with both AdsFas and sTNFRI.
28 schema:genre article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N24e76e98e9ca47a195ff9c9674dbacab
32 Ne6f59501aa55469095503878cd15f543
33 sg:journal.1112551
34 schema:keywords AdLacZ.
35 CMV promoter
36 FA
37 Fas-induced liver apoptosis
38 Fas-mediated apoptosis
39 Jo2
40 Jo2-induced apoptosis
41 Kupffer cells
42 SFA
43 TNF
44 TNF receptor
45 addition
46 adenovirus
47 administration
48 amount
49 apoptosis
50 apoptosis of hepatocytes
51 cells
52 challenges
53 chloride
54 damage
55 different amounts
56 disease
57 disease process
58 early mortality
59 effect
60 effects of SFA
61 elevation
62 gadolinium chloride
63 hepatocellular damage
64 hepatocytes
65 infection
66 injection
67 lethal effects
68 levels
69 liver
70 liver apoptosis
71 liver cells
72 liver disease
73 liver transaminase levels
74 mice
75 mortality
76 one week
77 optimal protection
78 pathology
79 patients
80 possibility
81 pretreatment
82 process
83 production
84 production of TNF
85 promoter
86 protection
87 protective effect
88 protects
89 receptors
90 reduction
91 results
92 role
93 sTNFRI
94 sera of patients
95 serum
96 significant reduction
97 soluble Fas
98 soluble TNF receptors
99 survival
100 transaminase levels
101 treatment
102 vivo
103 weeks
104 schema:name Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-α production by Kupffer cells
105 schema:pagination 626-635
106 schema:productId N1ab9ab9bdd484bbeaca5623fa3c60032
107 N271f0f4816d2471c978805b50a39a0c6
108 Ne00abf86bdae4c729cffedc8c787df88
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030089876
110 https://doi.org/10.1038/sj.cdd.4401016
111 schema:sdDatePublished 2022-05-20T07:22
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N8bf9f5c5817b4fe4be07e9f7fbc10976
114 schema:url https://doi.org/10.1038/sj.cdd.4401016
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0273fe914c75426093e2183839226b28 rdf:first sg:person.07550405624.18
119 rdf:rest rdf:nil
120 N05d3d8e6b2464c9a869d1f1e61c670a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name fas Receptor
122 rdf:type schema:DefinedTerm
123 N0ff5190fd4fd4b93b094a6959fc0629a rdf:first sg:person.01054374560.30
124 rdf:rest N0273fe914c75426093e2183839226b28
125 N1ab9ab9bdd484bbeaca5623fa3c60032 schema:name pubmed_id
126 schema:value 12032671
127 rdf:type schema:PropertyValue
128 N24e76e98e9ca47a195ff9c9674dbacab schema:issueNumber 6
129 rdf:type schema:PublicationIssue
130 N271f0f4816d2471c978805b50a39a0c6 schema:name doi
131 schema:value 10.1038/sj.cdd.4401016
132 rdf:type schema:PropertyValue
133 N30b43525ebda4583988a631949cae70c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Apoptosis
135 rdf:type schema:DefinedTerm
136 N4238563f00b942429f76e553b30665ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Immunohistochemistry
138 rdf:type schema:DefinedTerm
139 N57af9373843141548a8664ae767a77b1 rdf:first sg:person.01062167667.01
140 rdf:rest Nf7a698a58fac4bcc91d12a41aa82d8a5
141 N5aa77d7938b042e89f92034828f2b462 rdf:first sg:person.016612437322.42
142 rdf:rest Nfcba42cb9596485d991f3d41f414205b
143 N5bc7348565ef4b0cbf67126d314efb88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Tumor Necrosis Factor-alpha
145 rdf:type schema:DefinedTerm
146 N6a6b1454f26c475995d4d22a4469593c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Mice, Inbred C57BL
148 rdf:type schema:DefinedTerm
149 N6fa3a95bcf5b4853a9d7b3a195c88bed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Solubility
151 rdf:type schema:DefinedTerm
152 N7af22a04eb6c404a92d37c75090b059d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Kupffer Cells
154 rdf:type schema:DefinedTerm
155 N8172de6f65484696bc66f627bcb3c456 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Mice
157 rdf:type schema:DefinedTerm
158 N86c1683092ef44beb29b201a0b7bb7ca rdf:first sg:person.0644012610.82
159 rdf:rest N0ff5190fd4fd4b93b094a6959fc0629a
160 N8bf9f5c5817b4fe4be07e9f7fbc10976 schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 N916de416f617425584ea268283ffa7d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Hepatitis
164 rdf:type schema:DefinedTerm
165 N9f28e61484c5436f8238109635630174 rdf:first sg:person.01010406464.77
166 rdf:rest N57af9373843141548a8664ae767a77b1
167 Nab89e9c360ac4e76b901659f1cddc376 rdf:first sg:person.010200342162.02
168 rdf:rest N86c1683092ef44beb29b201a0b7bb7ca
169 Nc1e7c3c96b4f417db7c68416937ee681 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Gadolinium
171 rdf:type schema:DefinedTerm
172 Nc46bb39e6bea468f850d159924b511b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Animals
174 rdf:type schema:DefinedTerm
175 Nc68ef871d1834a769864ce0aeea6b451 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Female
177 rdf:type schema:DefinedTerm
178 Nc6b13588f52649308f096bc10a42862d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Genetic Therapy
180 rdf:type schema:DefinedTerm
181 Ncf1ad0912ba44a4682eec3c8861a94a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Antibodies
183 rdf:type schema:DefinedTerm
184 Nd5beeda543534ad7a77b9c225c5954f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Hepatocytes
186 rdf:type schema:DefinedTerm
187 Ne00abf86bdae4c729cffedc8c787df88 schema:name dimensions_id
188 schema:value pub.1030089876
189 rdf:type schema:PropertyValue
190 Ne2ad258e347d4fbeb2f09ba7e5c3576b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Hemorrhage
192 rdf:type schema:DefinedTerm
193 Ne6f59501aa55469095503878cd15f543 schema:volumeNumber 9
194 rdf:type schema:PublicationVolume
195 Ne90a89aa79fe4dc084444e2ad4495695 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Liver
197 rdf:type schema:DefinedTerm
198 Neac54be6e2084cd1ad7e3f0108f39c5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Male
200 rdf:type schema:DefinedTerm
201 Nf7a698a58fac4bcc91d12a41aa82d8a5 rdf:first sg:person.01263522210.53
202 rdf:rest N5aa77d7938b042e89f92034828f2b462
203 Nfcba42cb9596485d991f3d41f414205b rdf:first sg:person.0740752222.20
204 rdf:rest Nab89e9c360ac4e76b901659f1cddc376
205 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
206 schema:name Medical and Health Sciences
207 rdf:type schema:DefinedTerm
208 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
209 schema:name Clinical Sciences
210 rdf:type schema:DefinedTerm
211 sg:grant.2425848 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.cdd.4401016
212 rdf:type schema:MonetaryGrant
213 sg:grant.2446046 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.cdd.4401016
214 rdf:type schema:MonetaryGrant
215 sg:grant.2454082 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.cdd.4401016
216 rdf:type schema:MonetaryGrant
217 sg:grant.2454874 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.cdd.4401016
218 rdf:type schema:MonetaryGrant
219 sg:journal.1112551 schema:issn 1350-9047
220 1476-5403
221 schema:name Cell Death & Differentiation
222 schema:publisher Springer Nature
223 rdf:type schema:Periodical
224 sg:person.01010406464.77 schema:affiliation grid-institutes:grid.265892.2
225 schema:familyName Matsuki
226 schema:givenName Y
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010406464.77
228 rdf:type schema:Person
229 sg:person.010200342162.02 schema:affiliation grid-institutes:grid.417886.4
230 schema:familyName Edwards
231 schema:givenName C K
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010200342162.02
233 rdf:type schema:Person
234 sg:person.01054374560.30 schema:affiliation grid-institutes:grid.280808.a
235 schema:familyName Zhang
236 schema:givenName H-G
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054374560.30
238 rdf:type schema:Person
239 sg:person.01062167667.01 schema:affiliation grid-institutes:grid.265892.2
240 schema:familyName Li
241 schema:givenName L
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062167667.01
243 rdf:type schema:Person
244 sg:person.01263522210.53 schema:affiliation grid-institutes:grid.265892.2
245 schema:familyName Hsu
246 schema:givenName H-C
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01263522210.53
248 rdf:type schema:Person
249 sg:person.016612437322.42 schema:affiliation grid-institutes:grid.265892.2
250 schema:familyName Yang
251 schema:givenName P A
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016612437322.42
253 rdf:type schema:Person
254 sg:person.0644012610.82 schema:affiliation grid-institutes:grid.265892.2
255 schema:familyName Chaudry
256 schema:givenName I H
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644012610.82
258 rdf:type schema:Person
259 sg:person.0740752222.20 schema:affiliation grid-institutes:grid.265892.2
260 schema:familyName Zheng
261 schema:givenName R
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740752222.20
263 rdf:type schema:Person
264 sg:person.07550405624.18 schema:affiliation grid-institutes:grid.280808.a
265 schema:familyName Mountz
266 schema:givenName J D
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07550405624.18
268 rdf:type schema:Person
269 sg:pub.10.1038/3488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051953130
270 https://doi.org/10.1038/3488
271 rdf:type schema:CreativeWork
272 sg:pub.10.1038/364806a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050650199
273 https://doi.org/10.1038/364806a0
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/nm0497-409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028570463
276 https://doi.org/10.1038/nm0497-409
277 rdf:type schema:CreativeWork
278 grid-institutes:grid.265892.2 schema:alternateName Center for Surgical Research and Department of Surgery, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA
279 Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA
280 schema:name Center for Surgical Research and Department of Surgery, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA
281 Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA
282 rdf:type schema:Organization
283 grid-institutes:grid.280808.a schema:alternateName Birmingham Veterans Administration Medical Center, AL 35233, Birmingham, Alabama, USA
284 schema:name Birmingham Veterans Administration Medical Center, AL 35233, Birmingham, Alabama, USA
285 Division of Clinical Immunology and Rheumatology, Department of Medicine, The University of Alabama at Birmingham, AL 35294, Birmingham, Alabama, USA
286 rdf:type schema:Organization
287 grid-institutes:grid.417886.4 schema:alternateName Amgen Inc. Thousand Oaks, CA 91320, California, USA
288 schema:name Amgen Inc. Thousand Oaks, CA 91320, California, USA
289 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...